{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-25-000111","form_type":"8-K","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2025-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.606993+00:00","generated_at":"2026-05-16T17:30:24.057614+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Labcorp appoints Novartis U.S. President Victor Bulto to Board of Directors","bullets":["Victor Bulto appointed to Labcorp's Board effective December 1, 2025; he is President of Novartis U.S. and member of Novartis Executive Committee.","Bulto brings 25 years of healthcare experience and oversees Novartis' $20B+ U.S. business across oncology, immunology, neuroscience, and cardiovascular-renal-metabolic areas.","CEO Adam Schechter stated Bulto's expertise in therapeutic areas and transformation will support Labcorp's innovation and long-term growth strategy.","Bulto will receive compensation consistent with Labcorp's director compensation program as described in the April 4, 2025 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-25-000111","json":"https://secwatch.observer/filing/0000920148-25-000111.json","markdown":"https://secwatch.observer/filing/0000920148-25-000111.md","text":"https://secwatch.observer/filing/0000920148-25-000111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014825000111/0000920148-25-000111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014825000111/lh-20251120.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:30:24.057614+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}